Fazzini P F, Pucci P D, Santoro G M, Buonamici P, Buzzigoli A, Sarro F
G Ital Cardiol. 1987 Mar;17(3):239-45.
A study was undertaken in order to compare the effects of Diltiazem, Nifedipine and Verapamil on 11 male adults (aged 44 to 70 yrs: mean age 60 yrs) affected by effort angina with a stable exercise threshold. The study was carried out according to a 4 week double-blind randomized protocol. Diltiazem (300 mg/die), Nifedipine (50 mg/die), Verapamil (400 mg/die) and placebo were administered each for 7 day periods. An ergometric test was performed on the last of each therapeutic cycle in order to evaluate the effects of the treatments. The three active drugs globally provoked an increased tolerance to physical effort with respect to placebo (p less than 0.01); no significant differences, as regards physical performance, could be detected among the three drugs. Treatment with Nifedipine significantly increased heart rate at rest (p less than 0.05), under submaximal (p less than 0.05) and maximal load (p less than 0.05), with respect to treatment with Diltiazem and Verapamil. Systolic and diastolic arterial blood pressure did not vary significantly with any of the three drugs. Rate pressure product under submaximal load (p less than 0.05) and at the end of the exercise (p less than 0.05) was higher with Nifedipine than with the other two drugs. These results show that patient response to Nifedipine is different from that to Verapamil and Diltiazem and suggest that the three drugs exert their anti ischemic effect through different mechanisms. The evaluation of individual response revealed that only one patient showed no increased tolerance to physical effort with any of the drugs.(ABSTRACT TRUNCATED AT 250 WORDS)
为比较地尔硫䓬、硝苯地平和维拉帕米对11名患有劳力性心绞痛且运动阈值稳定的成年男性(年龄44至70岁,平均年龄60岁)的影响,开展了一项研究。该研究按照为期4周的双盲随机方案进行。地尔硫䓬(300毫克/日)、硝苯地平(50毫克/日)、维拉帕米(400毫克/日)和安慰剂均给药7天。在每个治疗周期的最后一天进行运动测试,以评估治疗效果。与安慰剂相比,三种活性药物总体上提高了对体力活动的耐受性(p小于0.01);在三种药物之间,未检测到关于身体表现的显著差异。与地尔硫䓬和维拉帕米治疗相比,硝苯地平治疗使静息心率(p小于0.05)、次最大负荷(p小于0.05)和最大负荷(p小于0.05)下的心率显著增加。三种药物中的任何一种对收缩压和舒张压均无显著影响。硝苯地平治疗在次最大负荷下(p小于0.05)和运动结束时(p小于0.05)的率压乘积高于其他两种药物。这些结果表明,患者对硝苯地平的反应不同于对地尔硫䓬和维拉帕米的反应,并提示这三种药物通过不同机制发挥抗缺血作用。个体反应评估显示,只有一名患者使用任何一种药物后对体力活动的耐受性均未增加。(摘要截选至250字)